Two teens with powerful stories about their experience in drug treatment have been awarded the top distinction in the MusiCares and Grammy Foundation’s Teen Substance Abuse Awareness through Music Contest. The annual contest was created to celebrate National Drug Facts Week and is coordinated by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Related posts:
- Medicare, Teen musicians win GRAMMY experience for songs about drug abuse NIH collaborates with MusiCares and GRAMMY Foundation to honor teen musicians during National Drug Facts Week Three original music compositions that focus on personal experience living around drugs were the winners of the MusiCares and GRAMMY Foundation’s Teen Substance Abuse Awareness through Music Contest. The contest was created to celebrate National Drug Facts Week, a […]...
- MusiCares, GRAMMY Foundation announce 2011 Teen contest Today marks the launch of the second annual MusiCares and GRAMMY Foundation Teen Substance Abuse Awareness through Music Contest. Announced by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, along with MusiCares and the GRAMMY Foundation — the two nonprofit organizations of The Recording Academy — the contest asks […]...
- HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published […]...
- NIDA, Federal Partners, Launch National Drug Facts Week Expanding on the success of its online Drug Facts Chat Day, the National Institute on Drug Abuse (NIDA) today announced it is launching National Drug Facts Week, a new national awareness week designed to bring together teens and scientific experts to discuss the facts about drug abuse. NIDA is a component of the National Institutes […]...
- Second Annual National Drug Facts Week Begins Oct. 31st Teens and drug experts will connect for the second annual National Drug Facts Week, held Oct. 31 through Nov. 6. This week-long observance will bring together teens and scientific experts in community events across the country to discuss scientific facts about drug abuse. It is sponsored by the National Institute on Drug Abuse (NIDA), a […]...
- Medicare, Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health....
- Painkiller abuse treated by sustained buprenorphine/naloxone People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday’s Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health....
- NIH-supported mouse studies suggest treatment target for alcohol problems A molecular pathway within the brain’s reward circuitry appears to contribute to alcohol abuse, according to laboratory mouse research supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). The findings, published online today in Proceedings of the National Academy of Sciences, also provide evidence that […]...
- Graduated drivers licensing programs reduce fatal teen crashes Programs that grant privileges to new drivers in phases — known as graduated licensing programs — dramatically reduce the rate of teen driver fatal crashes, according to three studies funded by the National Institutes of Health....
- Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....
- MedicareCard.com – NIH Podcast Shines Light on Prescription Drug Abuse in Women NIH Podcast...
- Study finds hospitalizations increase for alcohol and drug overdoses Hospitalizations for alcohol and drug overdoses — alone or in combination — increased dramatically among 18- to 24-year-olds between 1999 and 2008, according to a study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
- Brain Chemical Linked to Joylessness Provides Insight Into Teen Depression Depressed teens with anhedonia, or the inability to experience pleasure, have lower levels of the neurotransmitter GABA in a key mood-regulating region of the brain, according to an NIMH-funded study published online October 3, in the Archives of General Psychiatry....
- MedicareCard.com Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina....
- Clinical trial stopped on combination cholesterol treatment The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular […]...